| 1A4Y | B:; E: | RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX |
| 1ANG | A: | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REVEALS THE STRUCTURAL BASIS FOR ITS FUNCTIONAL DIVERGENCE FROM RIBONUCLEASE |
| 1AWZ | A: | 3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN DETERMINED BY 1H, 15N NMR SPECTROSCOPY, 30 STRUCTURES |
| 1B1E | A: | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT K40Q |
| 1B1I | A: | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN |
| 1B1J | A: | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT H13A. |
| 1GV7 | A: | ARH-I, AN ANGIOGENIN/RNASE A CHIMERA |
| 1H0D | C: | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F |
| 1H52 | A: | BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY |
| 1H53 | A: | BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY |
| 1HBY | A: | BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY |
| 1K58 | A: | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT D116H |
| 1K59 | A: | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT Q117G |
| 1K5A | A: | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN DOUBLE VARIANT I119A/F120A |
| 1K5B | A: | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT DES(121-123) |
| 1UN3 | A: | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T44D |
| 1UN4 | A: | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T80A |
| 1UN5 | A: | ARH-II, AN ANGIOGENIN/RNASE A CHIMERA |
| 2ANG | A: | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN OF THE MET(-1) FORM |
| 4AHD | A:; B: | Q12L - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS |
| 4AHE | A: | K17I - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS |
| 4AHF | A: | K17E - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS |
| 4AHG | A: | S28N - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS |
| 4AHH | A: | R31K - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS |
| 4AHI | A: | K40I - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS |
| 4AHK | A:; B: | K54E - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS |
| 4AHL | A: | P112L - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS |
| 4AHM | A: | V113I - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS |
| 4AHN | A: | R121H - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS |
| 4AOH | A: | STRUCTURAL SNAPSHOTS AND FUNCTIONAL ANALYSIS OF HUMAN ANGIOGENIN VARIANTS ASSOCIATED WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
)
)